The Diana Jacobs Kalman/AFAR Scholarships for Research in the Biology of Aging

Sponsor: American Federation for Aging Research (AFAR)

Award: Each scholarship is $5,000. No indirect costs or overhead are allowed.

Due Date: April 15, 2025.

Glenn Foundation Discovery Award

Sponsor: Glenn Foundation for Medical Research (GFMR), American Federation for Aging Research (AFAR)

Award: Up to two three-year awards will be made in 2025. Each award is for $525,000 payable in annual installments of $175,000 per year, of which a maximum of 8% may be used for indirect expenses or institutional overhead (not to exceed $12,963 per year).

Due Date: LOI Deadline: February 18, 2025.

Notice of Special Interest (NOSI): Alzheimers and Alzheimers-related Dementias (AD/ADRD) Focused Competitive Revisions to Existing NIH Grants that are not focused on AD/ADRD (NOT-AG-24-073)

Sponsor: National Institutes of Health

Award: Applications for this initiative must be submitted using the following opportunity or its subsequent reissued equivalent: PA-23-317- Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional)

Due Date: This notice applies to due dates on or after March 6, 2025 and subsequent receipt dates through March 7, 2025.

NIA Postdoctoral Fellowship Award to Promote Broad Participation in Translational Research for AD/ADRD (F32 Clinical Trial Not Allowed) (PAR-24-332)

Sponsor: National Institute on Aging

Due Date: Multiple due dates; see announcement.

NIA Predoctoral Fellowship Award to Promote Broad Participation in Translational Research for AD/ADRD (F31 Clinical Trial Not Allowed) (PAR-24-333)

Sponsor: National Institute on Aging

Due Date: Multiple due dates; see announcement.

Notice of Special Interest (NOSI): Genetic Underpinnings of Endosomal Trafficking as a Pathological Hub in Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (NOT-AG-24-029)

Sponsor: National Institute on Aging

Award: Submit applications for this initiative using one of the following notices of funding opportunities (NOFOs) or any reissues of these announcements through the expiration date of this notice: PAR-25-331 - Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R21 Clinical Trial Not Allowed); PAR-25-332 - Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R01 Clinical Trial Optional)

Due Date: This notice applies to due dates on or after March 11, 2025 and subsequent receipt dates through November 17, 2027.

Notice of Special Interest (NOSI): Common Mechanisms and Interactions Among Neurodegenerative Diseases (NOT-AG-24-031)

Sponsor: National Institute on Aging

Award: Submit applications for this initiative using one of the following notices of funding opportunities (NOFOs) or any reissues of these announcements through the expiration date of this notice: PAR-25-331 - Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R21 Clinical Trial Optional); PAR-25-332 - Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R01 Clinical Trial Optional).

Due Date: This notice applies to due dates on or after March 11, 2025 and subsequent receipt dates through November 17, 2027.

Notice of Special Interest (NOSI): Understanding Alzheimer's Disease in the Context of the Aging Brain (NOT-AG-24-032)

Sponsor: National Institute on Aging

Award: Submit applications for this initiative using one of the following notices of funding opportunities (NOFOs) or any reissues of these announcements through the expiration date of this notice: PAR-25-331 - Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R21 Clinical Trial Optional); PAR-25-332 - Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R01 Clinical Trial Optional).

Due Date: This notice applies to due dates on or after March 11, 2025 and subsequent receipt dates through November 17, 2027.

Science & PINS Prize for Neuromodulation

Sponsor: American Association for the Advancement of Science (AAAS) and Beijing PINS Medical Equipment Co. Ltd.

Award: The winner of the Science & PINS Prize for Neuromodulation will be awarded $25,000 and have their essay published in Science. The runner-up will be awarded $5,000 and have their essay published on Science Online.

Due Date: March 15, 2025.

Prospective Observational Comparative Effectiveness Research in Clinical Neurosciences (UG3/UH3 Clinical Trial Not Allowed) (PAR-25-048)

Sponsor: National Institute of Neurological Disorders and Stroke

Due Date: Multiple due dates; see announcement.

Unveiling Health and Healthcare Disparities in Non-Communicable and Chronic Diseases in Latin America (R01 - Clinical Trials Not Allowed) (PAR-25-377)

Sponsor: National Institutes of Health

Due Date: Multiple due dates; see announcement.

Notice of Special Interest (NOSI): Selective Cell and Network Vulnerability in Aging and Alzheimers Disease (NOT-AG-24-033)

Sponsor: National Institute on Aging

Award: Submit applications for this initiative using one of the following notices of funding opportunities (NOFOs) or any reissues of these announcements through the expiration date of this notice: PAR-25-331 - Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R21 Clinical Trial Optional); PAR-25-332 - Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R01 Clinical Trial Optional)

Due Date: This notice applies to due dates on or after March 11, 2025 and subsequent receipt dates through November 17, 2027.

Notice of Special Interest (NOSI): Major Opportunities for Research in Epidemiology of Alzheimer's Disease and Alzheimer's Disease-Related Dementias (AD/ADRD) and Cognitive Resilience (NOT-AG-24-042)

Sponsor: National Institute on Aging

Award: Submit applications for this initiative using one of the following notice of funding opportunity (NOFO) or any reissues of these announcements through the expiration date of this notice: PAR-25-331 - Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R21 Clinical Trial Optional); PAR-25-332 - Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R01 Clinical Trial Optional)

Due Date: This notice applies to due dates on or after March 11, 2025 and subsequent receipt dates through November 17, 2027.

Joint NINDS/NIMH Exploratory Neuroscience Research Grant (R21 Clinical Trial Not Allowed) (PA-25-150)

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS), National Institute of Mental Health (NIMH)

Award: Direct costs are limited to $275,000 over a two-year period, with no more than $200,000 in direct costs allowed in any single year.

Due Date: Multiple due dates; see announcement.

Trailblazer Award for New and Early Stage Investigators (R21 Clinical Trial Optional) (PA-25-169)

Sponsor: National Institutes of Health

Award: Application budgets may not exceed $400,000 direct costs over a maximum three-year funding period. No more than $200,000 direct costs may be requested in any single year.

Due Date: Multiple due dates; see announcement.